SCHEMBL523968

SCHEMBL523968

CN1CCCC1(CN)c1cccnc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
ALDH1A1 P00352 3/20 0.36
LMNA P02545 2/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
CHRNB2 P17787 4/20 0.36
CHRNA4 P43681 4/20 0.36
CHRNA7 P36544 2/20 0.35
CHRNB4 P30926 2/20 0.35
CHRNA3 P32297 2/20 0.35
CHRNA2 Q15822 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
HTR3E A5X5Y0 1/20 0.35
PSIP1 O75475 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL157279 1.00 MEN1 (0.36) MEN1KMT2ACHRM2CHRM4CHRM5
Succinic Acid SCHEMBL6376630 0.90 EPHX2 (0.43) MEN1KMT2AALDH1A1LMNASLC6A2
SCHEMBL156155 0.87 MEN1 (0.37) MEN1KMT2ACHRM2CHRM4CHRM5
SCHEMBL1538392 0.87 MEN1 (0.37) MEN1KMT2ACHRM2CHRM4CHRM5
SCHEMBL157125 0.86 MEN1 (0.39) MEN1KMT2ACHRM2CHRM4CHRM5
SCHEMBL968705 0.86 MEN1 (0.39) MEN1KMT2ACHRM2CHRM4CHRM5
SCHEMBL159477 0.84 MEN1 (0.36) MEN1KMT2ACHRM2CHRM4CHRM5
SCHEMBL156223 0.84 MEN1 (0.36) MEN1KMT2ACHRM2CHRM4CHRM5
SCHEMBL175825 0.82 MEN1 (0.34) MEN1KMT2ACHRM2CHRM4CHRM5
SCHEMBL2811768 0.82 MEN1 (0.44) MEN1KMT2AALDH1A1LMNACHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130142821-A1 Hapten-Carrier Conjugates and Uses Thereof CYTOS BIOTECHNOLOGY AG (CH) 2013-06-06 US claimed
US-8187607-B2 Hapten-carrier conjugates and uses thereof CYTOS BIOTECHNOLOGY AG (CH) 2012-05-29 US claimed
EP-2392345-A2 Hapten-carrier conjugates comprising virus like particles and uses thereof Cytos Biotechnology AG (CH) 2011-12-07 EP claimed
JP-2011524521-A 2011-09-01 JP claimed
EP-2320898-A2 SMOKING CESSATION KIT AND METHOD Nabi Biopharmaceuticals (US) 2011-05-18 EP claimed
US-20100129395-A1 Hapten-carrier conjugates and uses thereof CYTOS BIOTECHNOLOGY AG (CH) 2010-05-27 US claimed
WO-2009152164-A2 SMOKING CESSATION KIT AND METHOD NABI BIOPHARMACEUTICALS (US) 2009-12-17 WO claimed
CN-100518823-C Hapten-carrier conjugates and uses thereof CYTOS BIOTECHNOLOGY AG (CH) 2009-07-29 CN claimed
JP-2006504654-A 2006-02-09 JP claimed
CN-1668331-A Hapten-carrier conjugates and uses thereof CYTOS BIOTECHNOLOGY AG (CH) 2005-09-14 CN claimed
EP-1523334-A2 HAPTEN-CARRIER CONJUGATES AND USES THEREOF Cytos Biotechnology AG (CH) 2005-04-20 EP claimed
US-20040059094-A1 Hapten-carrier conjugates and uses thereof CYTOS BIOTECHNOLOGY AG (CH) 2004-03-25 US claimed
WO-2004009116-A2 HAPTEN-CARRIER CONJUGATES COMPRISING VIRUS LIKE PARTICLES AND USES THEREOF CYTOS BIOTECHNOLOGY AG (CH) 2004-01-29 WO claimed
CN-110452217-B Optically pure haptens for nicotine vaccine development 斯克利普斯研究院 2022-12-27 CN disclosed
US-11278608-B2 Nicotine nanovaccines and uses thereof VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 2022-03-22 US disclosed
EP-2346528-B1 NICOTINE IMMUNONANOTHERAPEUTICS MASSACHUSETTS INST TECHNOLOGY (US) 2016-04-06 EP disclosed
US-6932971-B2 Hapten-carrier conjugates and uses thereof CYTOS BIOTECHNOLOGY AG (CH) 2005-08-23 US disclosed
EP-1523334-A2 HAPTEN-CARRIER CONJUGATES AND USES THEREOF Cytos Biotechnology AG (CH) 2005-04-20 EP disclosed
US-20040059094-A1 Hapten-carrier conjugates and uses thereof CYTOS BIOTECHNOLOGY AG (CH) 2004-03-25 US disclosed
WO-2004009116-A2 HAPTEN-CARRIER CONJUGATES COMPRISING VIRUS LIKE PARTICLES AND USES THEREOF CYTOS BIOTECHNOLOGY AG (CH) 2004-01-29 WO disclosed